Citigroup »

Lexaria Bioscience shares owned by Citigroup

Quarter-by-quarter ownership of Lexaria Bioscience (LEXX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Lexaria Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Lexaria Bioscience held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexaria Bioscience by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $380 489 0.78

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Lexaria Bioscience

Invenomic Capital Management
Geode Capital Management
Vanguard Group
Vanguard Capital Management
Toronto-Dominion Bank
Vanguard Fiduciary Trust
UBS Group
State Street Corporation
BlackRock
Vontobel Holding
Krilogy Financial
Hrt Financial
Northern Trust
Renaissance Technologies
Bank Of Montreal

View all funds holding Lexaria Bioscience